All treatments
Treatment
Matching placebo tablet, JNJ-67953964 clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open-label Long-term Extension Treatment with Aticaprant
This study is looking into a new medication, Aticaprant, for adults with depression who feel little pleasure and whose current treatments aren't working well enough. It aims to see if Aticaprant, taken with their usual antidepressant, can improve their mood and help them feel better.
For: Major Depressive Disorder (MDD) with Moderate-to-severe AnhedoniaBelgium · Bulgaria · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia
This study is looking into a new medication, JNJ-67953964, to help stop depression from coming back in people who also feel unable to experience pleasure. It compares this new drug with a dummy pill, alongside standard antidepressant treatment, to see how well it works.
For: Major Depressive Disorder (MDD) with Moderate-to-severe AnhedoniaBulgaria · Greece · Spain